Literature DB >> 22562537

Peppermint oil solution is useful as an antispasmodic drug for esophagogastroduodenoscopy, especially for elderly patients.

Atsushi Imagawa1, Hidenori Hata, Morihito Nakatsu, Yasunari Yoshida, Keiko Takeuchi, Toshihiro Inokuchi, Takayuki Imada, Yoshiyasu Kohno, Masahiro Takahara, Kazuyuki Matsumoto, Hirokazu Miyatake, Satoru Yagi, Masaharu Ando, Mamoru Hirohata, Shigeatsu Fujiki, Ryuta Takenaka.   

Abstract

BACKGROUND: Although hyoscine butyl bromide (HB) and glucagon (GL) are often used as antispasmodic drugs during esophagogastroduodenoscopy (EGD), these agents may cause adverse effects. Recently, it was reported that peppermint oil solution (PO) was very effective and had few side effects. AIM: We clarified the efficacy and usefulness of PO as an antispasmodic during upper endoscopy, especially for elderly patients.
METHODS: This study was a non-randomized prospective study. The antispasmodic score (1-5, where 5 represents no spasm) was defined according to the degree of spasms of the antrum and difficulty of biopsy. We compared the antispasmodic scores between non-elderly patients (younger than 70) and elderly patients (70 years old or older) according to the antispasmodic agent.
RESULTS: A total of 8,269 (Group PO: HB: GL: NO (no antispasmodic) = 1,893: 6,063: 157: 156) EGD procedures were performed. There was no significant difference in the antispasmodic score between Group PO (mean score ± standard deviation: 4.025 ± 0.925) and Group HB (4.063 ± 0.887). Among the non-elderly patients, those in Group PO (n = 599, 3.923 ± 0.935) had a worse antispasmodic score than those in Group HB (n = 4,583, 4.062 ± 0.876, P < 0.001). However, among the elderly patients, those in Group PO (n = 1,294, 4.073 ± 0.917) had similar scores to those in Group HB (n = 1,480, 4.064 ± 0.921, P = 0.83), and significantly better scores than those in Group GL (n = 69, 3.797 ± 0.933, P < 0.05).
CONCLUSION: Peppermint oil was useful as an antispasmodic during EGD, especially for elderly patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562537     DOI: 10.1007/s10620-012-2194-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia.

Authors:  B May; S Köhler; B Schneider
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

2.  Efficacy of peppermint oil as an antispasmodic during endoscopic retrograde cholangiopancreatography.

Authors:  Natsuyo Yamamoto; Yousuke Nakai; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Hiroyuki Isayama; Yutaka Komatsu; Minoru Tada; Mimoru Tada; Haruhiko Yoshida; Takao Kawabe; Naoki Hiki; Michio Kaminishi; Hanzo Kurosaka; Masao Omata
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

3.  Peppermint oil and colon spasm.

Authors:  J G Kingham
Journal:  Lancet       Date:  1995-10-14       Impact factor: 79.321

4.  Influence of peppermint oil on absorptive and secretory processes in rat small intestine.

Authors:  A Beesley; J Hardcastle; P T Hardcastle; C J Taylor
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

5.  An easy method for the intraluminal administration of peppermint oil before colonoscopy and its effectiveness in reducing colonic spasm.

Authors:  T Asao; E Mochiki; H Suzuki; J Nakamura ; I Hirayama; N Morinaga; H Shoji; Y Shitara; H Kuwano
Journal:  Gastrointest Endosc       Date:  2001-02       Impact factor: 9.427

6.  Does peppermint oil relieve spasm during barium enema?

Authors:  M J Sparks; P O'Sullivan; A A Herrington; S K Morcos
Journal:  Br J Radiol       Date:  1995-08       Impact factor: 3.039

7.  Delayed release peppermint oil capsules (Colpermin) for the spastic colon syndrome: a pharmacokinetic study.

Authors:  K W Somerville; C R Richmond; G D Bell
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

8.  Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.

Authors:  G Cappello; M Spezzaferro; L Grossi; L Manzoli; L Marzio
Journal:  Dig Liver Dis       Date:  2007-04-08       Impact factor: 4.088

9.  Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis.

Authors:  M H Pittler; E Ernst
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

10.  Risk management for gastrointestinal endoscopy in elderly patients: questionnaire for patients undergoing gastrointestinal endoscopy.

Authors:  Eiji Umegaki; Shinya Abe; Satoshi Tokioka; Nozomi Takeuchi; Toshihisa Takeuchi; Yukiko Yoda; Mitsuyuki Murano; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2009-12-29       Impact factor: 3.114

View more
  8 in total

Review 1.  Current and future role of magnetically assisted gastric capsule endoscopy in the upper gastrointestinal tract.

Authors:  Hey-Long Ching; Melissa Fay Hale; Mark Edward McAlindon
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

2.  Antiperistaltic effect and safety of L-menthol for esophagogastroduodenoscopy in the elderly with contraindication to hyoscine-N-butylbromide.

Authors:  Tsung-Chieh Yang; Ping-Hsien Chen; Ming-Chih Hou; Li-Ning Peng; Ming-Hsien Lin; Liang-Kung Chen; Yi-Hsiang Huang
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 3.  Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.

Authors:  B P Chumpitazi; G L Kearns; R J Shulman
Journal:  Aliment Pharmacol Ther       Date:  2018-01-26       Impact factor: 8.171

4.  l-Menthol sprayed on gastric mucosa causes edematous change.

Authors:  Akihiro Mori; Hiroki Hachiya; Takayuki Yumura; Shun Ito; Shintaro Hayashi; Masashi Nozaki; Atsui Yoshida; Noritsugu Ohashi
Journal:  Endosc Int Open       Date:  2014-06-23

5.  The influence of duodenally-delivered Shakuyakukanzoto (Shao Yao Gan Cao Tang) on duodenal peristalsis during endoscopic retrograde cholangiopancreatography: a randomised controlled trial.

Authors:  Haruka Fujinami; Shinya Kajiura; Jun Nishikawa; Takayuki Ando; Toshiro Sugiyama
Journal:  Chin Med       Date:  2017-01-09       Impact factor: 5.455

6.  Assessment of Cimetropium Bromide Use for the Detection of Gastric Neoplasms During Esophagogastroduodenoscopy.

Authors:  Sang Yoon Kim; Jae Myung Park; Hyun Sun Cho; Yu Kyung Cho; Myung-Gyu Choi
Journal:  JAMA Netw Open       Date:  2022-03-01

7.  Effectiveness of oral phloroglucinol as a premedication for unsedated esophagogastroduodenoscopy: A prospective, double-blinded, placebo-controlled, randomized trial.

Authors:  HyeIn Jung; Hyun Jung Kim; Eun Sung Choi; Ju Yup Lee; Kyung Sik Park; Kwang Bum Cho; Yoo Jin Lee
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

Review 8.  Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review.

Authors:  Hannah Ayrle; Meike Mevissen; Martin Kaske; Heiko Nathues; Niels Gruetzner; Matthias Melzig; Michael Walkenhorst
Journal:  BMC Vet Res       Date:  2016-06-06       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.